- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Current Gerontology and Geriatrics Research
Volume 2012 (2012), Article ID 412536, 6 pages
Aging and Down Syndrome
1Department of Molecular and Biomedical Pharmacology, Sanders-Brown Center on Aging, University of Kentucky, 800 South Limestone Street, Lexington, KY 40536, USA
2Kennedy Krieger Institute, Johns Hopkins University School of Medicine, 707 N. Broadway, Baltimore, MD 21205, USA
3Eleanor Roosevelt Institute and the Department of Biological Sciences, University of Denver, 2101 E. Wesley Avenue, Denver, CO 80208, USA
4Department of Pediatrics and Neurology, School of Medicine, University of California-Irvine (UCI), 101 The City Dr. ZC 4482, Orange, CA 92868, USA
Received 15 May 2012; Accepted 15 May 2012
Copyright © 2012 Elizabeth Head et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [6 citations]
The following is the list of published articles that have cited the current article.
- Ana M. Cardenas, Alvaro O. Ardiles, Natalia Barraza, Ximena Baez-Matus, and Pablo Caviedes, “Role of Tau Protein in Neuronal Damage in Alzheimer's Disease and Down Syndrome,” Archives Of Medical Research, vol. 43, no. 8, pp. 645–654, 2012.
- Giovanna Cenini, Ada Fiorini, Rukhsana Sultana, Marzia Perluigi, Jian Cai, Jon B. Klein, Elizabeth Head, and D. Allan Butterfield, “An Investigation of the Molecular Mechanisms Engaged Prior and Subsequent to the Development of Alzheimer Disease Neuropathology in Down Syndrome: A Proteomics Approach,” Free Radical Biology and Medicine, 2014.
- Dean Hartley, Thomas Blumenthal, Maria Carrillo, Gilbert DiPaolo, Lucille Esralew, Katheleen Gardiner, Ann-Charlotte Granholm, Khalid Iqbal, Michael Krams, Cynthia Lemere, Ira Lott, William Mobley, Seth Ness, Ralph Nixon, Huntington Potter, Roger Reeves, Marwan Sabbagh, Wayne Silverman, Benjamin Tycko, Michelle Whitten, and Thomas Wisniewski, “Down syndrome and Alzheimer's disease: Common pathways, common goals,” Alzheimer's & Dementia, 2014.
- Aleksandra Gruszecka, Przemysław Kopczyński, Dorota Cudziło, Natalia Lipińska, Aleksandra Romaniuk, Wojciech Barczak, Natalia Rozwadowska, Ewa Totoń, and Błażej Rubiś, “Telomere Shortening in Down Syndrome Patients—When Does It Start?,” DNA and Cell Biology, pp. 150318121959001, 2015.
- Andrea Romano, Marta Moraschi, Riccardo Cornia, Alessandro Bozzao, Olga Gagliardo, Laura Chiacchiararelli, Cristina Iani, Giacomo Stella, Giorgio Albertini, and Alberto Pierallini, “Age effects on cortical thickness in young Down’s syndrome subjects: a cross-sectional gender study,” Neuroradiology, 2015.
- Jin-Ding Lin, Lan-Ping Lin, Shang-Wei Hsu, Wen-Xiu Chen, Fu-Gong Lin, Jia-Ling Wu, and Cordia Chu, “Are early onset aging conditions correlated to daily activity functions in youth and adults with Down syndrome?,” Research in Developmental Disabilities, vol. 36, pp. 532–536, 2015.